Replies to post #5436 on Fibrocell Science Inc (FCSC)

[biolover]

Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the Oppenheimer 22nd Annual Healthcare Conference to be held on December 13-14, 2011 at the Waldorf=Astoria in New York City.

[DewDiligence]

We can argue semantics…

It’s not semantics, it’s arithmetic. A 50% decline from a share price of $0.44 is $0.22; a 100% decline from a share price of $0.44 is $0.00.